- Home
- VIST vs LNTH Comparison
VIST vs LNTH Comparison
Compare VIST & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIST | LNTH |
|---|---|---|
| Founded | 2017 | 1956 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.4B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VIST | LNTH |
|---|---|---|
| Price | $55.90 | $66.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $72.25 | ★ $78.00 |
| AVG Volume (30 Days) | 792.0K | ★ 795.8K |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.45 | N/A |
| EPS | ★ 6.75 | 2.39 |
| Revenue | ★ $2,226,451,000.00 | $1,525,933,000.00 |
| Revenue This Year | $42.80 | $0.01 |
| Revenue Next Year | $15.85 | $0.26 |
| P/E Ratio | ★ $7.75 | $28.34 |
| Revenue Growth | ★ 49.86 | 1.95 |
| 52 Week Low | $31.63 | $47.25 |
| 52 Week High | $56.85 | $111.29 |
Technical Indicators
Market Signals| Indicator | VIST | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 54.23 |
| Support Level | $47.78 | $63.37 |
| Resistance Level | $52.99 | $69.20 |
| Average True Range (ATR) | 1.96 | 1.92 |
| MACD | 0.84 | -0.25 |
| Stochastic Oscillator | 93.37 | 48.56 |
Price Performance
Historical ComparisonAbout VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.